KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
9.12
+0.16 (1.73%)
Nov 21, 2024, 2:04 PM EST - Market open

KalVista Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jul '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2019 - 2015
Net Income
-141.77-126.64-92.91-82.34-46.24-29.12
Upgrade
Depreciation & Amortization
0.850.820.720.560.540.51
Upgrade
Loss (Gain) From Sale of Investments
-1.29-1.231.133.150.53-0.11
Upgrade
Stock-Based Compensation
21.721.929.9211.097.124.45
Upgrade
Other Operating Activities
0.720.75-1.531.73-0.460.09
Upgrade
Change in Accounts Payable
5.714.321.111.690.15-1
Upgrade
Change in Unearned Revenue
------12.69
Upgrade
Change in Other Net Operating Assets
11.3610.856.31-14.018.2-6.95
Upgrade
Operating Cash Flow
-102.72-89.23-75.26-78.13-30.17-44.82
Upgrade
Capital Expenditures
-0.06-0.04-1.2-0.93-0.08-0.22
Upgrade
Sale (Purchase) of Intangibles
-0.47-0.4----
Upgrade
Investment in Securities
-66.65-84.2842.6158.79-147.5716.97
Upgrade
Investing Cash Flow
-67.17-84.7241.4257.86-147.6516.75
Upgrade
Long-Term Debt Repaid
------0.05
Upgrade
Net Debt Issued (Repaid)
------0.05
Upgrade
Issuance of Common Stock
100.3997.5957.031.58212.1211.64
Upgrade
Other Financing Activities
53.1253.121.09---
Upgrade
Financing Cash Flow
153.51150.7158.121.58212.1211.58
Upgrade
Foreign Exchange Rate Adjustments
-1.18-1.211.24-1.170.510.26
Upgrade
Net Cash Flow
-17.56-24.4525.51-19.8634.8-16.22
Upgrade
Free Cash Flow
-102.78-89.27-76.46-79.07-30.25-45.04
Upgrade
Free Cash Flow Margin
------354.89%
Upgrade
Free Cash Flow Per Share
-2.59-2.43-2.74-3.23-1.58-2.54
Upgrade
Levered Free Cash Flow
-57.84-50.27-52.01-60.09-21.2-37.71
Upgrade
Unlevered Free Cash Flow
-57.84-50.27-52.01-60.09-21.2-37.71
Upgrade
Change in Net Working Capital
-17.36-15.22-7.8410.42-7.4317.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.